The Lingering Threat: Managing Severe COVID-19 in the Postpandemic Era
June 12th 2025Although COVID-19 has receded quite a bit from the minds of many, it still remains a virus that can present serious morbidity and mortality. Here is a review of clinical treatment strategies by an intensivist when seeing patients with severe COVID-19.
Nationwide Avian Flu Response Gains Momentum, Yet Urgent Action Remains Essential
June 11th 2025The ongoing H5N1 avian flu outbreak has severely impacted U.S. poultry and dairy industries, prompting a $1 billion USDA response strategy that includes biosecurity, vaccination research, and innovation funding. With growing concern over viral mutations affecting humans and livestock, rapid, field-based diagnostic tools offer critical support in accelerating detection and containment efforts.
Top 5 Infectious Disease News stories Week of May 31-June 7
June 7th 2025This week, FDA approved Moderna’s improved COVID-19 vaccine mRNA, MAD-ID findings showed omadacycline’s 86% success rate in treating infections in immunocompromised patients, consistent safety in preventing recurrent CDI in patients with comorbidities, and more.
Gyre Therapeutics' Hydronidone Meets Primary Endpoint in Phase 3 Hepatitis B Trial
June 4th 2025Hydronidone demonstrated significant efficacy in liver fibrosis regression in CHB patients, meeting the primary endpoint in a phase 3 trial. The company plans to file regulatory applications in China and the US, aiming to expand the therapy's indications.
Federal Government Changes Course Again on COVID-19 Vaccine Policy
June 2nd 2025After the leaders of the NIH, FDA, and HHS made an announcement stating that both pregnant women and children were going to be taken off the COVID-19 immunization schedule, they decided to offer a new designation for the latter group, making it a shared decision between providers and patients.